EPISODE · Dec 30, 2025 · 33 MIN
William Blair Senior Biotech Analyst Andy Hsieh shares an overview of the obesity space heading into 2026
from BiotechTV - News · host BiotechTV
He discusses the recently approved Wegovy pill, and compares and contrasts it to other oral programs from Lilly, Structure, and Corbus. Plus, how is the amylin space looking compared to GLP-1s, and a preview of Viking's 2026.
Embed this episode
NOW PLAYING
William Blair Senior Biotech Analyst Andy Hsieh shares an overview of the obesity space heading into 2026
0:00
33:28
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of BiotechTV - News?
This episode is 33 minutes long.
When was this BiotechTV - News episode published?
This episode was published on December 30, 2025.
Can I download this BiotechTV - News episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!